Haibin Li1,2, Frank Qian3, Chenbei Hou1,2, Xia Li4, Qi Gao1,2, Yanxia Luo1,2, Lixin Tao1,2, Xinghua Yang1,2, Wei Wang5, Deqiang Zheng1,2, Xiuhua Guo1,2. 1. Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China. 2. Beijing Municipal Key Laboratory of Clinical Epidemiology, Capital Medical University, China. 3. Department of Medicine, University of Chicago, Illinois. 4. Department of Mathematics and Statistics, La Trobe University, Bundoora, Victoria, Australia. 5. Global Health and Genomics, School of Medical Sciences and Health, Edith Cowan University, Perth, Western Australia, Australia.
Abstract
BACKGROUND: There remains a relative paucity of evidence for the association between changes in depressive symptoms with cardiovascular disease (CVD) and mortality. This study aimed to evaluate the association of change in depressive symptoms and incident CVD and mortality in a large prospective cohort of middle-aged and older adults. METHODS: A total of 6,810 participants free of CVD in the China Health and Retirement Longitudinal Study with two assessments of depressive symptoms at wave 1 (2011-2012) and wave 2 (2013-2014) were included. Elevated depressive symptoms were defined as a score of ≥12 on the 10-item Center for Epidemiologic Studies Depression scale. We used a modified Poisson regression to examine the association of changes in depressive symptoms (never, onset, remitted, and persistent) and incident CVD (a composite endpoint of heart disease or stroke) and mortality at wave 3 (2015-2016). RESULTS: During follow-up, 457 CVDs and 148 deaths occurred. Multivariable analyses revealed that persistent depressive symptoms were associated with an elevated risk of CVD (risk ratio = 1.77, 95% confidence interval = 1.38-2.26) and mortality (risk ratio = 1.63, 95% confidence interval = 1.01-2.64) compared with participants without any depressive symptoms. New-onset depressive symptoms increased the mortality risk (risk ratio = 2.37, 95% confidence interval = 1.52-3.69), but not CVD (risk ratio = 1.15, 95% confidence interval = 0.84-1.58). Remitted depressive symptoms were associated with a 35% and 13% excess risk of CVD and mortality, respectively. CONCLUSION: Persistent and remitted depressive symptoms were associated with an increased risk of CVD. New-onset depressive symptoms predicted elevated mortality risk.
BACKGROUND: There remains a relative paucity of evidence for the association between changes in depressive symptoms with cardiovascular disease (CVD) and mortality. This study aimed to evaluate the association of change in depressive symptoms and incident CVD and mortality in a large prospective cohort of middle-aged and older adults. METHODS: A total of 6,810 participants free of CVD in the China Health and Retirement Longitudinal Study with two assessments of depressive symptoms at wave 1 (2011-2012) and wave 2 (2013-2014) were included. Elevated depressive symptoms were defined as a score of ≥12 on the 10-item Center for Epidemiologic Studies Depression scale. We used a modified Poisson regression to examine the association of changes in depressive symptoms (never, onset, remitted, and persistent) and incident CVD (a composite endpoint of heart disease or stroke) and mortality at wave 3 (2015-2016). RESULTS: During follow-up, 457 CVDs and 148 deaths occurred. Multivariable analyses revealed that persistent depressive symptoms were associated with an elevated risk of CVD (risk ratio = 1.77, 95% confidence interval = 1.38-2.26) and mortality (risk ratio = 1.63, 95% confidence interval = 1.01-2.64) compared with participants without any depressive symptoms. New-onset depressive symptoms increased the mortality risk (risk ratio = 2.37, 95% confidence interval = 1.52-3.69), but not CVD (risk ratio = 1.15, 95% confidence interval = 0.84-1.58). Remitted depressive symptoms were associated with a 35% and 13% excess risk of CVD and mortality, respectively. CONCLUSION: Persistent and remitted depressive symptoms were associated with an increased risk of CVD. New-onset depressive symptoms predicted elevated mortality risk.
Authors: Zumin Shi; Stephen J Nicholls; Anne W Taylor; Dianna J Magliano; Sarah Appleton; Paul Zimmet Journal: J Hypertens Date: 2018-01 Impact factor: 4.844
Authors: Jennifer L St Sauver; Philip T Hagen; Stephen S Cha; Stephanie M Bagniewski; Jayawant N Mandrekar; Ann M Curoe; Richard J Rodeheffer; Veronique L Roger; Steven J Jacobsen Journal: Mayo Clin Proc Date: 2005-02 Impact factor: 7.616
Authors: Sophie A Vreeburg; Witte J G Hoogendijk; Johannes van Pelt; Roel H Derijk; Jolanda C M Verhagen; Richard van Dyck; Johannes H Smit; Frans G Zitman; Brenda W J H Penninx Journal: Arch Gen Psychiatry Date: 2009-06
Authors: Paola Gilsanz; Stefan Walter; Eric J Tchetgen Tchetgen; Kristen K Patton; J Robin Moon; Benjamin D Capistrant; Jessica R Marden; Laura D Kubzansky; Ichiro Kawachi; M Maria Glymour Journal: J Am Heart Assoc Date: 2015-05-13 Impact factor: 5.501
Authors: Golam M Khandaker; Verena Zuber; Jessica M B Rees; Livia Carvalho; Amy M Mason; Christopher N Foley; Apostolos Gkatzionis; Peter B Jones; Stephen Burgess Journal: Mol Psychiatry Date: 2019-03-19 Impact factor: 15.992